Genitourinary Radiology: Page 10

PSMA-PET shows value in primary staging of prostate cancer

By Will Morton

Prostate-specific membrane antigen (PSMA) PET/CT imaging can reveal metastatic bone cancer lesions in prostate cancer patients that may be undetected by conventional bone scintigraphy, according to a group in the Netherlands.

January 5, 2023

MRI-targeted prostate biopsy protocol halves overdiagnosis

By Kate Madden Yee

A prostate cancer biopsy protocol based on targeted MRI rather than systemic ultrasound shows promise for reducing overdiagnosis by half, according to study results published December 8 in the New England Journal of Medicine.

December 7, 2022

Does contrast-enhanced CT boost kids' acute kidney injury risk?

By Kate Madden Yee

Does contrast-enhanced CT boost the incidence of acute kidney injury in children? It doesn't seem so, according to a study published December 6 in Radiology.

December 7, 2022

Can AI improve diagnostic accuracy for prostate MRI?

By Erik L. Ridley

Monday, November 28 | 1:30 p.m.-2:30 p.m. | M6-SSGU03-5 | Room S406BPreliminary results from a large Dutch study suggest that an artificial intelligence (AI) algorithm could help improve diagnostic accuracy in interpreting prostate MRI exams.

November 13, 2022

MRI after PSA testing is more cost-effective than standard protocol

By Kate Madden Yee

Prostate cancer screening that combines prostate-specific antigen (PSA) testing followed by an MRI is more cost-effective than the traditional pathway of PSA to standard biopsy, according to a study published November 10 in JAMA Oncology.

November 10, 2022

Blue Earth moves toward U.K. prostate radiopharmaceutical licensing

By AuntMinnie.com staff writers

Blue Earth Therapeutics has secured an "innovation passport" from the U.K.'s Innovative Licensing and Access Pathway for its investigational therapeutic radiopharmaceutical lutetium-177 rhPSMA-10.1 for treatment of metastatic prostate cancer.

November 8, 2022

Telix highlights kidney cancer imaging study results

By AuntMinnie.com staff writers

Telix Pharmaceuticals is highlighting positive clinical results from a study that has tested its investigational kidney cancer PET imaging agent, TLX250-CDx.

November 6, 2022

Week in review: CT or ultrasound for kidney stones? | Final 2023 Medicare reimbursement rules | PET/CT for melanoma

By Erik L. Ridley

November 4, 2022

PSMA-PET improves radical prostate surgery

By Will Morton

PET imaging with prostate-specific antigen (PSMA) radiotracers can help surgeons spare nerves in patients undergoing radical prostatectomy, according to a study published November 1 in Urologic Oncology.

November 1, 2022

Which is better for diagnosing kidney stones, CT or ultrasound?

By Kate Madden Yee

CT is the dominant imaging tool in the emergency department for diagnosing and evaluating kidney stones, but it may not be the best, according to a research letter published October 31 in JAMA Internal Medicine.

November 1, 2022

Breast, prostate cancer diagnoses still lag after pandemic

By AuntMinnie.com staff writers

The number of diagnoses of breast and prostate cancer still remain significantly below levels reached prior to the COVID-19 pandemic, according to research from Quest Diagnostics published October 10 in the Journal of Clinical Oncology (JCO) Clinical Cancer Informatics.

October 10, 2022

RSIP Vision ships AI tool for 3D ureter reconstruction

By AuntMinnie.com staff writers

Artificial intelligence (AI) software developer RSIP Vision has introduced software that can provide 3D reconstructions of 2D fluoroscopic images of the ureter.

October 3, 2022

Previous Page

Page 10 of 93

Next Page